NeuroCreis
Biotechnology Research • 
United States • 1-10 Employees
Company overview
| Headquarters | United States |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at NeuroCreis
Mark Bacon
Chief Technology Officer
NeuroCreis Email Formats
NeuroCreis uses 1 email format. The most common is {last name} (e.g., doe@neurocreis.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name} | doe@neurocreis.com | 100% |
About NeuroCreis
At NeuroCreis, we value healthy aging, living life to the fullest free from neurological disorders. NeuroCreis is advancing breakthrough drug discoveries using proprietary screening technology, the first and only to utilize primary adult neural cells with age, sex, and multi-specie validation measures. Our mission is to develop novel therapeutic strategies for neurotrauma and neurodegenerative diseases. We are focused on improving mobility and cognition, areas where no clinical treatments exist.
NeuroCreis revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
NeuroCreis has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
NeuroCreis has never raised funding before.
NeuroCreis Tech Stack
Discover the technologies and tools that power NeuroCreis's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
PaaS
Blogs
Miscellaneous
Programming languages
Miscellaneous
Security
JavaScript frameworks
Blogs
IaaS
Switzerland
Spain
AustraliaFrequently asked questions
4.8
40,000 users
